Saturday, June 28, 2025
Linkedin Twitter
Linkedin Twitter
Home Blog Page 405

WKH & Natural Standard Partner to Streamline Access to Evidence-Based Complementary & Alternative Medicine Resources

Wolters Kluwer Health and Natural Standard, the authority on integrative medicine, are pleased to announce a partnership to expand access to Natural Standard Database through Ovid’s medical research platform. Produced by The Natural Standard Research Collaboration, this up-to-date repository contains thousands of evidence-based systematic reviews on dietary supplements and other complementary and alternative medical (CAM) practices including modalities, special diets, and exercises.

Natural Standard reviews are compiled by over 500 experts in clinical trial analysis, epidemiology, pharmacology, and toxicology. Searchable monograph sections include study result summaries, statistical analysis of clinical trials, dosing, drug interactions, precautions, contraindications, adverse effects, allergies, use in pregnancy and lactation. Natural products, physical and mind-body therapies are rated with validated, reproducible evidence “report cards” based on scientific study criteria used by the respected U.S. Preventive Task Force.

Additional features include Continuing Medical Education (CME) credits made available to multidisciplinary professionals to earn in real time. Tools such as interactive calculators, symptom and interaction checkers, and patient handouts in multiple languages are also included to help improve health care decision-making and outcomes.

“As the use of supplements and alternative therapies continues to increase in the United States and around the world, it made perfect sense to collaborate with Natural Standard to bring this unique resource to Ovid’s global user,” said Andrew Richardson, Vice President Business Development, Wolters Kluwer Health Medical Research.

“High utilization rates and consumer demand require healthcare providers to have a solid understanding of the safety and efficacy of dietary supplements and integrative therapies,” said Dr. Catherine Ulbricht, Chief Editor at Natural Standard. “The Ovid platform, with its emphasis on smart, precise searching and ease of access, allows larger international audiences to benefit from our combined resources.”

F1000Research articles will be listed in PubMed, and deposited in PubMed Central

F1000Research, the first Open Science publisher, announces that articles published in its innovative publishing system will be listed in PubMed, the world’s largest and most-used biomedical literature database.

F1000Research is F1000’s new open access publishing program that offers immediate publication followed by a thorough and completely open peer review process, executed after publication. Following recent approval by the National Library of Medicine (NLM)’s Selections group, all articles that pass this peer review process will now be listed in PubMed and deposited within PubMed Central.

F1000Research’s acceptance by the NLM Selections group follows agreements confirmed with Elsevier in 2012 for the indexing of F1000Research articles in Scopus and Embase.

Jisc secures agreement to provide a continuing legacy for schools resource

Jisc is delighted to have finalised an agreement to preserve and host the Vital subject portals, an invaluable resource for schools.

From 1 April 2013, management of the established subject and special interest portals will move from The Open University. The portals direct teachers to some of the best subject resources available, helping to bring about innovation in the classroom to inspire learners.

Guy Lambert, CEO of Jisc Advance said: “We are delighted that the DfE and The Open University selected us to provide a legacy for the Vital programme. We’re looking forward to taking over the reins of these established resource portals, accessed by up to 6,000 users every year. Over time, we aspire to be in a position to extend the value the Vital portals already deliver to the curriculum and to teaching and learning. Vital currently serves teachers in England; our ambition is for all teachers across the UK to benefit from this invaluable resource.”

The portals will be free to access, complementing Jisc Advance’s new subscription offer to schools which is due to be launched in Spring 2013. This service will provide local hands-on practical support to:

• Optimise the use of schools’ and academies’ existing technologies
• Link the use of technology to improvements in learning outcomes and progression
• Provide opportunities to share with and learn from peers
• Provide open access to resources and professional development opportunities.

Peter Twining, director of Vital, commented, “I’m thrilled with this agreement with Jisc Advance which is a win-win for everyone concerned. It provides a huge endorsement of the work Vital has been doing, it will help Jisc raise its profile within schools, and most importantly ensures the ongoing support for teachers that the Vital subject portals provide.”

Current Vital users will be contacted by Vital in Spring 2013 informing them of the changes and increased benefits. They will be offered the opportunity for their registrations to be transferred to Jisc to ensure continuity of service. Users can rest assured that the portals will remain similar with possible enhancements introduced in the future.

Free app brings Thieme E-Book Library to the iPad

The collection of Thieme’s acclaimed E-Book Library is now available to institutional customers for the iPad. With the free iPublishCentral reader app, end-users within an institutional license can download all titles in the Thieme E-Book Library to their iPads and read them anywhere they want, even without an internet connection.

The iPublishCentral reader app, available free of charge in the iTunes store, now allows students, faculty, and researchers to download Thieme E-Book Library titles to their iPad for off-campus reading. Users only need to download the app to their iPad and access the Thieme E-Book Library within the IP range of their institution to download any title of the collections. New additions to the E-Book Library will also be available for download upon their release. “We provide unlimited downloads of full books by library patrons within the institutional license, delivering content to our users in whichever format they would like,” says Brian Scanlan, President of Thieme Publishers.

To access the Thieme E-Book Library, users need to be within the IP range of their university or institution. Once the book is downloaded to the iPad, however, it can be taken and read anywhere. No internet connection is required for reading, annotating, or searching the downloaded titles. In addition to a full-text search function, the iPublishCentral reader offers a user-friendly navigation via icons that provide easy access to notes, bookmarks, settings as well as the table of content.

Institutional subscribers may license Thieme E-Books for online use, making them available for their students, faculty, and other members. Titles downloaded to the iPad from the Thieme E-Book Library are available for one year, after which they can be re-downloaded provided that the institution still has a valid Thieme E-Book Library license.

The Thieme E-Book Library is an acclaimed, comprehensive online collection of downloadable textbooks with full-colour illustrations and a full-text search function. The electronic library covers every course in the medical school curriculum and is a valuable research, review and study resource for medical and life science students, faculty, and clinicians.

De Gruyter is expanding its program in North America. Staffing levels in the STM fields

De Gruyter will continue to expand at the beginning of 2013, its program department in the United States. The Boston office of the company is Alexander N. Greene build areas in the STM (Science, Technology, Medicine) and continuously evolve.

In recent years, De Gruyter had strengthened its liberal arts program in the U.S. market and for set of seven employees. The sales team has been systematically expanded to seven digits. Through this personal commitment could De Gruyter strengthen its market position and enhance its reputation in the American academic community greatly.

“With the new editorial offices in Boston, De Gruyter’s strategic expansion of its international program focused on,” said Dr. Sven Fund , CEO of De Gruyter. “The new colleagues will help to raise the international profile of our publishing house in the largest science fair of the world.”

McGraw-Hill Professional Expands Its Digital Offerings to Libraries

McGraw-Hill Professional today announced that it is offering an enhanced purchasing program for its popular McGraw-Hill eBook Library, a digital platform delivering unparalleled access to its premium content (MHeBookLibrary.com). This new purchasing alternative – perpetual access – is designed to give libraries more flexibility in acquiring McGraw-Hill Professional’s digital content to meet the growing demands from their patrons for eBooks.

The McGraw-Hill eBook Library includes nearly 2,000 titles in collections that are continuously updated with new eBooks. Users can access hundreds of thousands of pages of content from authors who are leading authorities in the areas of engineering, computing, medical, business, and student study aids.

Academic libraries will be interested in acclaimed reference works such as Harrison’s Manual of Medicine, Fundamentals of Radar Signal Processing, and the complete catalog of course study aides, Schaum’s Outlines. Public libraries will find a wealth of titles on careers and business skills, student and career exam study guides and the highly popular series of “How to Do Everything” books on consumer technology.

“In a fast-changing environment, McGraw-Hill Professional continues to provide new ways to deliver our content and respond to our customers’ needs,” said Philip Ruppel , president of McGraw-Hill Education International and Professional. “Our enhanced perpetual access program is another way to ensure that libraries around the world have all of the options they need to build eBook collections to best serve their patrons.”

The McGraw-Hill eBook Library At-A-Glance Facts:
Unlimited concurrent usage
Nearly 2,000 titles in the areas of:
Engineering
Personal Computing
Medical & Medical Test Prep
Business, Finance & Management
Student Study Aids

For more information about the McGraw-Hill eBook Library, including product demos, please visit www.MHeBookLibrary.com.

PR Newswire (http://s.tt/1yeSs)

Experimental & Molecular Medicine re-launches on nature.com

Experimental & Molecular Medicine (EMM) has re-launched on nature.com as a fully open access title. Co-published by Nature Publishing Group (NPG) and the Korean Society for Biochemistry and Molecular Biology (KSBMB), EMM is devoted to publishing the latest and most important advances in genetic, molecular and cellular studies of human physiology and diseases.

The journal re-launches with a revised aims and scope and publishes original research papers and reviews that communicate the improved clinical benefits for human health from the experimental and translational research performed using molecular tools. EMM provides a suitable platform for publishing studies involving basic discoveries with clinical relevance as well as those dealing with mechanisms, diagnosis and treatment of diseases.

The editorial team is led by Editor-in-Chief Professor Dae-Myung Jue with Professors Kyungho Choi, Sangdun Choi, Yoon-Keun Kim and Young-Han Lee as Associate Editors. A new international editorial board, composed of molecular biologists, biochemists and physicians, work with the editorial team of EMM to further define and shape the field of biomedical research.
“We are very excited to commence this new partnership with NPG,” said Professor Dae-Myung Jue, Editor-in-Chief of EMM. “We expect combining the publishing expertise of NPG with the fast-growing research in the field, especially in East Asia, will provide an ideal platform to address various medical problems that we face today.”

“The formation of the partnership between NPG and the KSBMB means that EMM, Korea’s first biochemistry journal, is also the first Korean journal to join the NPG Asia-Pacific journals program,” said Dr Dugald McGlashan, Publisher of NPG’s Asia-Pacific Academic Journals. “We look forward to working closely with the KSBMB on this truly international journal.”

EMM is the 15th journal published by NPG in the Asia-Pacific region, and joins over 60 journals in NPG’s journal portfolio that have either an open access option or are entirely open access. 58 of its 62 academic and society publications (94%) have introduced open access options or are open access journals. A full list of open access titles that NPG publishes is available on nature.com.

Brill Acquires Entomology List from Apollo Books

Brill, the international scholarly publisher, has finalized an agreement with Apollo Books (Denmark) to acquire the English-language Entomology publications program, effective immediately.

Brill, the international scholarly publisher, has finalized an agreement with Apollo Books in Denmark to acquire the English-language Entomology publications program as well as a small number of other Biology titles.The acquisition comprises of a number of book series, such as: Geometrid Moths of Europe, The Moths and Butterflies of Great Britain and Ireland, Palaearctic Macrolepidopteraand Microlepidoptera of Europe. Also included are 25 forthcoming titles and over 100 backlist titles.

The Entomology and other Biology titles fit well in Brill’s Biology program, building upon its systematic biology scope while bringing greater cross marketing and global distribution opportunities to the acquired list.

“I am happy that Brill will carry on our program,” says Peder Skou, Director of Apollo Books. “I regard them as a very well suited publisher to continue with this.”

Sam Bruinsma, Brill VP Business Development adds: “This agreement follows a previous deal in 2008 when we acquired the journal Insect Systematics and Evolution from Apollo Books, a publisher most highly regarded among the entomological community. ”

Effective immediately, Brill assumes publishing responsibilities for the acquired titles. As of 1 February stock will be available via Brill’s distribution channels.

EBSCO Publishing Acquires PEMSoft to Expand its Evidence-Based Pediatric Content

EBSCO Publishing (EBSCO) has expanded its evidence-based healthcare content with the acquisition of PEMSoft, a premiere pediatric point-of-care clinical information resource.

PEMSoft is an online clinical library and multimedia decision support system that addresses acute and chronic illness and injury conditions in children from newborn to young adult. PEMSoft was founded in 2003 by Ronald Dieckmann, MD, MPH, and Rob Pitt, MD. Dr. Dieckmann is Professor Emeritus of Pediatrics and Emergency Medicine at the University of California, San Francisco and served for 25 years as Director, Pediatric Emergency Medicine, San Francisco General Hospital. Dr. Pitt is Associate Professor of Pediatrics, University of Queensland, and served for 25 years as Director, Pediatric Emergency Medicine, Mater Children’s Hospital, Brisbane, Australia.

PEMSoft is available in either U.S. or U.K. English. The product features nearly 1,000 topics and nearly 3,000 proprietary high-quality medical images and videos, as well as several interactive tools for clinicians. The software is completely designed for fast, point-of-care use at the patient’s bedside. The extensive use of links, and intuitive navigation and search features make finding specialized topics easy. Popular modules include an extensive formulary with links to appropriate topics, medical calculators, as well as special sections for triage, signs and symptoms, procedures, quick reference and toxicology. Altogether, there are 41 sections in the vast PEMSoft database that address the entire spectrum of pediatric and neonatal disease and injury.

The unique and comprehensive resuscitation system “Resus Tool” provides exact treatment protocols, drug doses, infusion rates and equipment sizes for children with critical illnesses or injuries. The treatment interventions are based on the child’s length, weight or age and are totally customizable to the individual pediatric patient. Another interactive tool is “Calc” – a module that provides formulas and scoring systems for diagnosis and management of pediatric trauma, acute care, and critical care. PEMSoft’s medical images, massive medical content, and its innovative interactive tools make it unique among clinical information resources.

EBSCO Publishing Senior Vice President of Product Management and Customer Satisfaction, Stratton Lloyd, says that PEMSoft was developed by leaders in the pediatric field to support pediatric healthcare professionals in a wide variety of healthcare settings and complements other products to make EBSCO a leading content provider in a critical specialty. “Drs. Dieckmann and Pitt have created a vital tool for pediatric care that shares EBSCO’s commitment to providing evidence-based, current, point-of-care information. PEMSoft will make a perfect addition to our clinical information product line which includes products such as DynaMed, Nursing Reference Center and Patient Education Reference Center.”

PEMSoft’s editorial board includes renowned physicians from highly regarded institutions such as Baylor, Chicago Childrens Memorial Hospital, Children’s Hospital of Philadelphia, Duke, Stanford University, UCLA, and University of Washington. “The content development process that the experienced and diverse team of editors uses ensures that PEMSoft has the highest level of consistency, timeliness and quality,” says Dr. Dieckmann.

PEMSoft’s design and use of evidence-based content and multimedia elements help to assure access to online clinical information is fast, simple and intuitive. Dr. Pitt says that PEMSoft makes a difference throughout the clinical workflow. “PEMSoft has valuable content, organized in easy-to-find categories, so that doctors, nurses, physician assistants, nurse practitioners, paramedics and medical students can find what they need as quickly as possible.”

Dr.s Dieckmann and Pitt will continue their work as editors-in-chief with PEMSoft. More PEMSoft information is available at: http://www.pemsoft.com.

Elsevier Acquires Aureus Sciences, Provider of Databases and Information Tools

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the acquisition of Aureus Sciences, a Paris, France based privately held company that provides databases and information tools to pharmaceutical and biotech companies.

Formed in 2002, Aureus Sciences gathers unique and high quality quantitative biological activity data for major therapeutic drug targets. This content enables researchers to identify the most promising compounds, repurpose existing compounds and identify targets with which the new compounds might interact.

“The acquisition of Aureus Sciences provides us with tremendous opportunities to generate more value for our customers,” said Mark van Mierle, Managing Director Elsevier Pharmaceutical and Biotech Group. “With the combination of Aureus content assets and the content already available by Elsevier, we can create a valuable solution for those in need of improving speed and accuracy of lead-finding, decision-making and other key processes.”

The acquisition enables the combination of high quality and deeply extracted content from both companies to launch new solutions for our Pharmaceutical and Biotech customers. The first evidence of this will be seen early this year with the release of a new medicinal chemistry solution.

“The integration of Aureus into Elsevier, and the consolidation of best in class content, will complement Elsevier’s leadership in biomedical disciplines and strengthen our ability to offer new innovative databases to researchers in medicinal chemistry and pharmacology,” said Jason Theodosiou, CEO of Aureus Sciences. “We will see many positive synergies resulting from this combination.”

The acquisition is effective immediately and financial terms of the transaction are not being disclosed.

UK specialists welcome launch of ORCID as tool to identify researchers

Jisc joins organisations from across the UK higher education network to welcome the launch of the Open Researcher and Contributor Identifier (ORCID).

There are more academic articles being published than ever before and more authors working together. In order to be able to identify an author correctly a unique identifier is needed that can then link to each author’s publications. ORCID provides this link and if widely used would:

  • Ensure researchers get credit for their own work
  • Ensure researchers and learners looking for information will be able to find academic papers more accurately
  • Enable better management of researcher publication records, making it easier for them to create CVs, reduce form filling and improve reporting to funders
  • Create a means of linking information between institutions and systems internationally
  • Enable researchers to keep track of their own work with funders, publishers and institutions around the world.

It also provides researchers with their own ORCID. Researchers are able to control how much information it holds about them and who that is shared with. The adoption of ORCID is a solution to the current challenges of being able to search for work accurately. By researchers volunteering to adopt its usage it could improve discoverability and accurate referencing.

Neil Jacobs, programme director, Jisc comments: “We welcome the consensus that has been achieved on this issue, which should pave the way for better research systems, less work for researchers re-keying details, and more efficient operations across the sector.  We recognise that this is only the start and that work needs to be done to implement ORCID in the UK.  However, we have a solid beginning and we look forward to working with our partners across the sector to build on it.”

Alongside Jisc, the organisations below are encouraging the adoption of ORCID:

  • The Association of Research Managers and Administrators (ARMA)
  • The Higher Education Funding Council for England (HEFCE)
  • The Higher Education Statistics Agency (HESA)
  • Research Councils UK (RCUK)
  • The Universities and Colleges Information Systems Association (UCISA)
  • The Wellcome Trust.

Find out more about ORCID on Jisc’s website.

Elsevier Selected to Publish Cytotherapy: The Journal of Cell Therapy

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce that the International Society for Cellular Therapy (ISCT) has selected Elsevier to publish Cytotherapy: The Journal of Cell Therapy effective January 2013.

“Elsevier presented ISCT with unsurpassed reach into the global medical community, top class publishing services, and significant experience in this field. We are extremely confident that our collaboration with Elsevier will not only help Cytotherapy grow for the benefit of our members and readers, but also for the benefit of all scientists, technologists, regulators, manufacturing experts and others dedicated to translational development of safe and effective cell therapies,” said ISCT President, Kurt Gunter, MD, FASCP.

Cytotherapy is a highly influential publication in the mainstream of the rapidly expanding field of cell-based treatments for cancer, degenerative disorders, immunotherapy and stem cell transplantation. Cytotherapy publishes cutting edge findings, clinical trials of cell-based therapies, and news and opinion on all aspects of these disciplines. The journal focuses especially on the practical translation of scientific developments in the laboratory into clinical practice. Cytotherapy is an essential global resource for clinical researchers, oncologists, hematologists, doctors, and regulatory experts involved in cell processing and therapy.

Senior Editor of Cytotherapy, John Barrett, MD, commented, “What matters is ensuring that new peer-reviewed treatments, developments, and studies reach as many specialists working with cell therapies as possible. In this, I believe Elsevier offers an unrivaled opportunity to help the journal achieve this goal.”

Glen Campbell, Executive Vice President at Elsevier added, “Cytotherapy is an established and reputable journal and we are honored that the International Society for Cellular Therapy selected Elsevier as their publishing partner. Together, we will ensure that this prestigious title develops further as the leading global forum and resource for developing and supporting innovative cellular therapies.”

For more information go to: www.journals.elsevier.com/cytotherapy

1...404405406...486Page 405 of 486
© STM Publishing News 2025